During the past decade, Siteman Cancer Center at Saint Peters Hospital conducted 160 clinical trials. In the 10-year time frame, 160 clinical trials started and 59 clinical trials were completed, i.e. on average, 36.9% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 41 clinical trials were completed. i.e. 87.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Siteman Cancer Center at Saint Peters Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 99 trials, followed by "SWOG Cancer Research Network" with 28 trials sponsored, "Pfizer" with 25 trials sponsored, "Alliance for Clinical Trials in Oncology" with 19 trials sponsored and "NRG Oncology" with 19 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Siteman Cancer Center at Saint Peters Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 91 trials as a collaborator, "NRG Oncology" with 22 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "Radiation Therapy Oncology Group" with 4 trials as a collaborator and "Astellas Pharma Inc" with 3 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Siteman Cancer Center at Saint Peters Hospital" are "Stage IV Lung Cancer AJCC v8" (11 trials), "Invasive Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Breast Cancer AJCC v6 and v7" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Siteman Cancer Center at Saint Peters Hospital" in a lesser frequency.

Most popular intervention types in "Siteman Cancer Center at Saint Peters Hospital" are "Drug" (180 trials), "Other" (103 trials), "Biological" (84 trials), "Procedure" (63 trials) and "Radiation" (59 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (44 trials), "Laboratory Biomarker Analysis" (43 trials), "Computed Tomography" (35 trials), "Biospecimen Collection" (33 trials) and "Questionnaire Administration" (32 trials). Other intervention names were less common.

The vast majority of trials in "Siteman Cancer Center at Saint Peters Hospital" are 189 trials for "All" genders, 20 trials for "Male" genders and 11 trials for "Female" genders.

Currently, there are NaN active trials in "Siteman Cancer Center at Saint Peters Hospital". undefined are not yet recruiting, 78 are recruiting, 92 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Siteman Cancer Center at Saint Peters Hospital, 11 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Siteman Cancer Center at Saint Peters Hospital, 27 "Phase 1" clinical trials were conducted, 109 "Phase 2" clinical trials and 103 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".